Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 42 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1983 adjusted for splits and dividends. The latest closing stock price for Amgen as of June 04, 2025 is 287.01.
  • The all-time high Amgen stock closing price was 329.11 on September 20, 2024.
  • The Amgen 52-week high stock price is 346.85, which is 20.8% above the current share price.
  • The Amgen 52-week low stock price is 253.30, which is 11.7% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 302.19.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 286.7411 254.9490 324.4920 254.2700 287.0100 11.99%
2024 293.2592 283.8460 329.1120 252.7440 256.2860 -6.77%
2023 234.7975 241.3680 275.3230 201.2850 274.9020 13.46%
2022 224.0643 202.7150 267.8800 197.7610 242.2810 20.43%
2021 203.6112 196.5840 226.4500 177.8460 201.1770 0.89%
2020 198.0202 202.6400 223.3020 154.8990 199.4120 -1.99%
2019 162.9521 157.1800 205.2560 138.3380 203.4590 27.60%
2018 151.9959 140.8370 170.5720 133.1230 159.4490 15.23%
2017 134.0879 116.6690 150.9450 116.6690 138.3710 22.27%
2016 119.2815 119.4240 135.0370 103.9730 113.1700 -7.57%
2015 118.1398 118.2250 131.9110 99.2415 122.4340 3.95%
2014 96.1089 83.9977 126.9130 80.7659 117.7810 42.33%
2013 74.7865 63.4899 85.7366 58.4548 82.7501 34.80%
2012 53.9376 44.7942 64.2163 44.5497 61.3890 36.83%
2011 38.8587 38.4141 45.2344 33.3798 44.8641 18.17%
2010 38.5533 39.9147 42.2797 34.8251 37.9646 -2.95%
2009 37.9750 40.7930 44.5410 31.1946 39.1195 -2.04%
2008 35.3652 32.2250 45.5645 27.6402 39.9355 24.35%
2007 40.0561 47.3002 52.4520 32.1143 32.1143 -32.02%
2006 48.8514 55.5708 55.5708 44.2022 47.2380 -13.38%
2005 48.3713 44.4511 59.5886 39.5551 54.5335 22.93%
2004 40.7310 43.1165 45.7996 36.4433 44.3612 3.82%
2003 42.4907 34.1059 49.4716 33.8017 42.7292 27.82%
2002 34.1556 39.0019 43.2064 21.4856 33.4282 -14.35%
2001 43.0917 43.4795 51.3024 35.6204 39.0296 -11.73%
2000 45.2732 43.5227 53.9388 35.4838 44.2143 6.45%
1999 25.6592 18.5631 44.8626 18.0877 41.5346 129.77%
1998 11.5528 9.3248 18.1309 8.1470 18.0768 93.19%
1997 9.6340 9.4436 11.8208 7.9417 9.3572 -0.46%
1996 10.1152 10.0703 11.3237 8.9034 9.4004 -8.42%
1995 7.0466 5.0352 10.2648 4.8839 10.2648 101.27%
1994 4.1853 4.2464 5.1324 3.0565 5.1000 19.19%
1993 3.6349 6.1048 6.1157 2.7229 4.2788 -29.91%
1992 5.5746 6.4615 6.7208 4.3220 6.1048 -6.77%
1991 3.9052 1.8369 6.5479 1.6640 6.5479 265.05%
1990 1.1382 0.7419 1.8260 0.6447 1.7937 154.10%
1989 0.6318 0.4610 0.8644 0.4592 0.7059 45.19%
1988 0.4406 0.4646 0.5150 0.3710 0.4862 8.87%
1987 0.4645 0.3404 0.6411 0.2341 0.4466 40.93%
1986 0.2914 0.1819 0.4088 0.1801 0.3169 62.93%
1985 0.1105 0.0685 0.2089 0.0667 0.1945 169.76%
1984 0.0791 0.1044 0.1189 0.0522 0.0721 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $155.704B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $222.734B 16.62
Gilead Sciences (GILD) United States $135.999B 14.12
Vertex Pharmaceuticals (VRTX) United States $114.655B 0.00
Bristol Myers Squibb (BMY) United States $97.867B 6.55
GSK (GSK) United Kingdom $83.478B 9.92
CSL (CSLLY) Australia $77.222B 0.00
Regeneron Pharmaceuticals (REGN) United States $52.672B 12.78
Alnylam Pharmaceuticals (ALNY) United States $39.608B 0.00
Argenex SE (ARGX) Netherlands $35.208B 96.10
BeiGene (ONC) Cayman Islands $29.799B 0.00
BioNTech SE (BNTX) Germany $27.799B 0.00
Biogen (BIIB) United States $19.318B 8.33
Royalty Pharma (RPRX) United States $18.717B 7.91
Genmab (GNMSF) Denmark $14.008B 14.32
Genmab (GMAB) Denmark $13.690B 15.36
Insmed (INSM) United States $13.311B 0.00
Incyte (INCY) United States $12.990B 98.69
Illumina (ILMN) United States $12.954B 24.57
Exelixis (EXEL) United States $11.636B 19.75
BioMarin Pharmaceutical (BMRN) United States $10.891B 17.69
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Moderna (MRNA) United States $10.755B 0.00
Ascendis Pharma (ASND) Denmark $10.633B 0.00
Exact Sciences (EXAS) United States $10.345B 0.00
QIAGEN (QGEN) Netherlands $10.065B 19.58
Blueprint Medicines (BPMC) United States $8.241B 0.00
Roivant Sciences (ROIV) United Kingdom $8.024B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.926B 0.00
Bio-Techne Corp (TECH) United States $7.647B 28.53
Revolution Medicines (RVMD) United States $7.559B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.220B 0.00
Repligen (RGEN) United States $6.989B 78.24
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.802B 6.55
Halozyme Therapeutics (HALO) United States $6.569B 12.57
TG Therapeutics (TGTX) United States $5.780B 151.71
Telix Pharmaceuticals (TLX) Australia $5.738B 0.00
Guardant Health (GH) United States $5.673B 0.00
Nuvalent (NUVL) United States $5.614B 0.00
Axsome Therapeutics (AXSM) United States $5.421B 0.00
Legend Biotech (LEGN) United States $5.224B 0.00
Alkermes (ALKS) Ireland $5.156B 13.84
Zealand Pharma (ZLDPF) Denmark $4.996B 0.00
ADMA Biologics Inc (ADMA) United States $4.885B 36.54
Vaxcyte (PCVX) United States $4.470B 0.00
Merus (MRUS) Netherlands $4.320B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.178B 0.00
Avidity Biosciences (RNA) United States $4.147B 0.00
Akero Therapeutics (AKRO) United States $4.114B 0.00
PTC Therapeutics (PTCT) United States $4.018B 6.99
Cytokinetics (CYTK) United States $3.822B 0.00
Sarepta Therapeutics (SRPT) United States $3.820B 0.00
Krystal Biotech (KRYS) United States $3.783B 29.16
ACADIA Pharmaceuticals (ACAD) United States $3.679B 32.32
Arcellx (ACLX) United States $3.590B 0.00
SpringWorks Therapeutics (SWTX) United States $3.523B 0.00
Alvotech (ALVO) Luxembourg $3.452B 19.74
Ultragenyx Pharmaceutical (RARE) United States $3.441B 0.00
Zai Lab (ZLAB) China $3.435B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.285B 0.00
Protagonist Therapeutics (PTGX) United States $3.165B 68.08
MoonLake Immunotherapeutics (MLTX) Switzerland $3.108B 0.00
Metsera (MTSR) United States $3.083B 0.00
Viking Therapeutics (VKTX) United States $2.989B 0.00
Scholar Rock Holding (SRRK) United States $2.938B 0.00
Kymera Therapeutics (KYMR) United States $2.838B 0.00
Immunovant (IMVT) United States $2.639B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.563B 0.00
Ascentage Pharma Group - (AAPG) China $2.417B 0.00
ImmunityBio (IBRX) United States $2.392B 0.00
Apellis Pharmaceuticals (APLS) United States $2.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.357B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.294B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.243B 0.00
Bavarian Nordic (BVNRY) Denmark $2.153B 11.38
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.124B 0.00
Vericel (VCEL) United States $2.093B 1385.67
Belite Bio (BLTE) United States $2.064B 0.00
CG Oncology (CGON) United States $2.042B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.028B 13.48
Denali Therapeutics (DNLI) United States $2.024B 0.00
Ligand Pharmaceuticals (LGND) United States $1.975B 0.00
Vera Therapeutics (VERA) United States $1.971B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.941B 0.00
Agios Pharmaceuticals (AGIO) United States $1.933B 0.00
Amicus Therapeutics (FOLD) United States $1.928B 208.67
NovoCure (NVCR) Jersey $1.900B 0.00
IDEAYA Biosciences (IDYA) United States $1.895B 0.00
Certara (CERT) United States $1.859B 34.73
Twist Bioscience (TWST) United States $1.850B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.845B 0.00
Apogee Therapeutics (APGE) United States $1.707B 0.00
Beam Therapeutics (BEAM) United States $1.697B 0.00
Disc Medicine (IRON) United States $1.642B 0.00
Biohaven (BHVN) United States $1.611B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.582B 0.00
Edgewise Therapeutics (EWTX) United States $1.561B 0.00
Adaptive Biotechnologies (ADPT) United States $1.510B 0.00
Janux Therapeutics (JANX) United States $1.505B 0.00
89BIO (ETNB) United States $1.485B 0.00
Liquidia Technologies (LQDA) United States $1.413B 0.00
GRAIL (GRAL) United States $1.387B 0.00
Travere Therapeutics (TVTX) United States $1.368B 0.00
Mesoblast (MESO) Australia $1.348B 0.00
MannKind (MNKD) United States $1.343B 27.62
ANI Pharmaceuticals (ANIP) United States $1.336B 13.76
Celldex Therapeutics (CLDX) United States $1.319B 0.00
BGM Group (BGM) China $1.315B 0.00
Structure Therapeutics (GPCR) United States $1.260B 0.00
Pacira BioSciences (PCRX) United States $1.222B 11.63
Dynavax Technologies (DVAX) United States $1.202B 71.50
Anbio Biotechnology (NNNN) Germany $1.180B 0.00
Viridian Therapeutics (VRDN) United States $1.179B 0.00
Novavax (NVAX) United States $1.176B 2.74
Arcus Biosciences (RCUS) United States $1.062B 0.00
Mineralys Therapeutics (MLYS) United States $1.055B 0.00
CureVac (CVAC) Germany $1.054B 5.11
WAVE Life Sciences (WVE) Singapore $1.002B 0.00
Geron (GERN) United States $1.000B 0.00
Spyre Therapeutics (SYRE) United States $0.999B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.963B 0.00
NeoGenomics (NEO) United States $0.963B 0.00
MiMedx (MDXG) United States $0.957B 23.14
Niagen Bioscience (NAGE) United States $0.928B 130.89
Nurix Therapeutics (NRIX) United States $0.921B 0.00
Pharvaris (PHVS) Netherlands $0.904B 0.00
CorMedix Inc (CRMD) United States $0.855B 57.32
Oculis Holding AG (OCS) Switzerland $0.849B 0.00
Zymeworks (ZYME) United States $0.840B 0.00
Praxis Precision Medicines (PRAX) United States $0.839B 0.00
LENZ Therapeutics (LENZ) United States $0.838B 0.00
Nuvation Bio (NUVB) United States $0.834B 0.00
UniQure (QURE) Netherlands $0.830B 0.00
Immunome (IMNM) United States $0.806B 0.00
Intellia Therapeutics (NTLA) United States $0.797B 0.00
ArriVent BioPharma (AVBP) United States $0.791B 0.00
Gyre Therapeutics (GYRE) United States $0.771B 205.50
Pharming Group (PHAR) Netherlands $0.764B 0.00
Replimune (REPL) United States $0.742B 0.00
Vir Biotechnology (VIR) United States $0.723B 0.00
Immatics (IMTX) Germany $0.715B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.708B 0.00
AnaptysBio (ANAB) United States $0.691B 0.00
AbCellera Biologics (ABCL) Canada $0.689B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Anavex Life Sciences (AVXL) United States $0.669B 0.00
Arbutus Biopharma (ABUS) United States $0.661B 0.00
Cogent Biosciences (COGT) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Sionna Therapeutics (SION) United States $0.639B 0.00
GH Research (GHRS) Ireland $0.629B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Iovance Biotherapeutics (IOVA) United States $0.608B 0.00
Keros Therapeutics (KROS) United States $0.607B 0.00
Bicara Therapeutics (BCAX) United States $0.600B 0.00
Maze Therapeutics (MAZE) United States $0.598B 0.00
Oric Pharmaceuticals (ORIC) United States $0.597B 0.00
Stoke Therapeutics (STOK) United States $0.595B 13.80
Trevi Therapeutics (TRVI) United States $0.594B 0.00
Upstream Bio (UPB) United States $0.583B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.581B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.575B 0.00
Dianthus Therapeutics (DNTH) United States $0.566B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.559B 0.00
Kura Oncology (KURA) United States $0.556B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.551B 0.00
Cullinan Therapeutics (CGEM) United States $0.529B 0.00
Sana Biotechnology (SANA) United States $0.528B 0.00
Opthea (OPT) Australia $0.525B 0.00
Tyra Biosciences (TYRA) United States $0.512B 0.00
Arvinas (ARVN) United States $0.511B 0.00
REGENXBIO (RGNX) United States $0.508B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Abivax SA (ABVX) France $0.491B 0.00
Castle Biosciences (CSTL) United States $0.482B 32.76
ATyr Pharma (ATYR) United States $0.480B 0.00
Eton Pharmaceuticals (ETON) United States $0.463B 0.00
MBX Biosciences (MBX) United States $0.457B 0.00
PureTech Health (PRTC) United States $0.453B 0.00
Celcuity (CELC) United States $0.452B 0.00
Myriad Genetics (MYGN) United States $0.450B 0.00
Rapport Therapeutics (RAPP) United States $0.447B 0.00
MeiraGTx Holdings (MGTX) United States $0.445B 0.00
Septerna (SEPN) United States $0.444B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.438B 0.00
Tectonic Therapeutic (TECX) United States $0.435B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.421B 0.00
Fortrea Holdings (FTRE) United States $0.419B 11.57
Erasca (ERAS) United States $0.409B 0.00
Sage Therapeutics (SAGE) United States $0.409B 0.00
Humacyte (HUMA) United States $0.405B 0.00
Precigen (PGEN) United States $0.401B 0.00
Benitec Biopharma (BNTC) United States $0.400B 0.00
Zenas BioPharma (ZBIO) United States $0.398B 0.00
Northwest Biotherapeutics (NWBO) United States $0.394B 0.00
Kamada (KMDA) Israel $0.387B 23.21
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Fulcrum Therapeutics (FULC) United States $0.380B 0.00
Rezolute (RZLT) United States $0.378B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.369B 0.00
Cytek Biosciences (CTKB) United States $0.361B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Absci (ABSI) United States $0.355B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.353B 0.00
Tango Therapeutics (TNGX) United States $0.351B 0.00
Emergent Biosolutions (EBS) United States $0.348B 0.00
Inventiva S.A (IVA) France $0.346B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.346B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.335B 0.00
Verastem (VSTM) United States $0.324B 0.00
Abeona Therapeutics (ABEO) United States $0.321B 0.00
Aura Biosciences (AURA) United States $0.318B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.316B 0.00
Entrada Therapeutics (TRDA) United States $0.313B 10.17
Alpha Teknova (TKNO) United States $0.307B 0.00
Terns Pharmaceuticals (TERN) United States $0.305B 0.00
Compass Therapeutics (CMPX) United States $0.296B 0.00
Allogene Therapeutics (ALLO) United States $0.295B 0.00
Neurogene (NGNE) United States $0.293B 0.00
Cidara Therapeutics (CDTX) United States $0.292B 0.00
XOMA Royalty (XOMA) United States $0.292B 0.00
Candel Therapeutics (CADL) United States $0.288B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.285B 58.00
Corvus Pharmaceuticals (CRVS) United States $0.281B 0.00
Astria Therapeutics (ATXS) United States $0.280B 0.00
Gossamer Bio (GOSS) United States $0.277B 0.00
Olema Pharmaceuticals (OLMA) United States $0.277B 0.00
Atea Pharmaceuticals (AVIR) United States $0.276B 0.00
Solid Biosciences (SLDB) United States $0.271B 0.00
Prima BioMed (IMMP) Australia $0.271B 0.00
Palvella Therapeutics (PVLA) United States $0.270B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Prothena (PRTA) Ireland $0.260B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.259B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Cartesian Therapeutics (RNAC) United States $0.257B 0.00
Lifecore Biomedical (LFCR) United States $0.254B 0.00
Aardvark Therapeutics (AARD) United States $0.253B 0.00
Annexon (ANNX) United States $0.252B 0.00
Ocugen (OCGN) United States $0.249B 0.00
Tvardi Therapeutics (TVRD) United States $0.248B 0.00
Amarin (AMRN) Ireland $0.247B 0.00
Foghorn Therapeutics (FHTX) United States $0.243B 0.00
MaxCyte (MXCT) United States $0.242B 0.00
Third Harmonic Bio (THRD) United States $0.237B 0.00
Semper Paratus Acquisition (TVGN) United States $0.235B 0.00
Cardiff Oncology (CRDF) United States $0.234B 0.00
Urogen Pharma (URGN) United States $0.231B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.228B 0.00
Design Therapeutics (DSGN) United States $0.228B 0.00
GENFIT S.A (GNFT) France $0.225B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.221B 0.00
Adherex Technologies (FENC) United States $0.218B 0.00
DBV Technologies S.A (DBVT) France $0.217B 0.00
EnGene Holdings (ENGN) Canada $0.214B 0.00
CytomX Therapeutics (CTMX) United States $0.214B 5.52
Adocia (ADOCY) France $0.213B 0.00
BioStem Technologies (BSEM) $0.208B 8.47
Kodiak Sciences (KOD) United States $0.208B 0.00
CARGO Therapeutics (CRGX) United States $0.208B 0.00
ScPharmaceuticals (SCPH) United States $0.203B 0.00
Monopar Therapeutics (MNPR) United States $0.196B 0.00
Innate Pharma S.A (IPHA) France $0.196B 0.00
Instil Bio (TIL) United States $0.196B 0.00
Inhibrx Biosciences (INBX) United States $0.196B 0.12
Codexis (CDXS) United States $0.194B 0.00
Bright Minds Biosciences (DRUG) United States $0.193B 0.00
Actuate Therapeutics (ACTU) United States $0.191B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.190B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.187B 0.00
Nuvectis Pharma (NVCT) United States $0.187B 0.00
Voyager Therapeutics (VYGR) United States $0.182B 0.00
DiaMedica Therapeutics (DMAC) United States $0.177B 0.00
Prime Medicine (PRME) United States $0.175B 0.00
INmune Bio (INMB) United States $0.167B 0.00
Anika Therapeutics (ANIK) United States $0.166B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.166B 0.00
AC Immune (ACIU) Switzerland $0.166B 0.00
Puma Biotechnology (PBYI) United States $0.165B 4.31
Galena Biopharma (SLS) United States $0.164B 0.00
Compugen (CGEN) Israel $0.163B 0.00
Alumis (ALMS) United States $0.163B 0.00
Alpha Cognition (ACOG) Canada $0.157B 0.00
Fate Therapeutics (FATE) United States $0.156B 0.00
I-Mab (IMAB) United States $0.153B 0.00
Editas Medicine (EDIT) United States $0.152B 0.00
Alector (ALEC) United States $0.148B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.146B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
BioAge Labs (BIOA) United States $0.143B 0.00
Black Diamond Therapeutics (BDTX) United States $0.142B 41.67
Ventyx Biosciences (VTYX) United States $0.142B 0.00
Agenus (AGEN) United States $0.137B 0.00
Rapt Therapeutics (RAPT) United States $0.131B 0.00
Elicio Therapeutics (ELTX) United States $0.129B 0.00
TuHURA Biosciences (HURA) United States $0.128B 0.00
Greenwich LifeSciences (GLSI) United States $0.128B 0.00
Seer (SEER) United States $0.126B 0.00
Nkarta (NKTX) United States $0.126B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.124B 0.00
Contineum Therapeutics (CTNM) United States $0.123B 0.00
Kyverna Therapeutics (KYTX) United States $0.121B 0.00
Neumora Therapeutics (NMRA) United States $0.120B 0.00
Theratechnologies (THTX) Canada $0.120B 0.00
EXoZymes (EXOZ) United States $0.119B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Invivyd (IVVD) United States $0.116B 0.00
Sagimet Biosciences (SGMT) United States $0.111B 0.00
Cabaletta Bio (CABA) United States $0.111B 0.00
BioHarvest Sciences (BHST) Canada $0.109B 0.00
C4 Therapeutics (CCCC) United States $0.105B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.103B 0.00
23andMe Holding (MEHCQ) United States $0.103B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
TScan Therapeutics (TCRX) United States $0.099B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.098B 0.00
Caribou Biosciences (CRBU) United States $0.098B 0.00
Adagene (ADAG) China $0.098B 0.00
Genelux (GNLX) United States $0.097B 0.00
Nautilus Biotechnology (NAUT) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.095B 0.00
Entera Bio (ENTX) Israel $0.094B 0.00
Biomea Fusion (BMEA) United States $0.094B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.092B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.091B 0.00
Coherus BioSciences (CHRS) United States $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
Jasper Therapeutics (JSPR) United States $0.089B 0.00
XBiotech (XBIT) United States $0.088B 0.00
Climb Bio (CLYM) United States $0.087B 0.00
Senti Biosciences (SNTI) United States $0.082B 0.00
Cellectis S.A (CLLS) France $0.081B 0.00
Whitehawk Therapeutics (WHWK) United States $0.080B 0.00
Elutia (ELUT) United States $0.080B 0.00
Tenaya Therapeutics (TNYA) United States $0.080B 0.00
Genenta Science S.p.A (GNTA) Italy $0.080B 0.00
Inovio Pharmaceuticals (INO) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.077B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.077B 0.00
IGM Biosciences (IGMS) United States $0.075B 0.00
Zura Bio (ZURA) United States $0.073B 0.00
Alto Neuroscience (ANRO) United States $0.071B 0.00
Skye Bioscience (SKYE) United States $0.071B 0.00
Immuneering (IMRX) United States $0.071B 0.00
Immunic (IMUX) United States $0.070B 0.00
PDS Biotechnology (PDSB) United States $0.070B 0.00
MediciNova (MNOV) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Exicure (XCUR) United States $0.066B 0.00
Citius Oncology (CTOR) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
Adicet Bio (ACET) United States $0.064B 0.00
OKYO Pharma (OKYO) $0.063B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.063B 0.00
Forte Biosciences (FBRX) United States $0.063B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
TELA Bio (TELA) United States $0.062B 0.00
Seres Therapeutics (MCRB) United States $0.061B 0.00
Werewolf Therapeutics (HOWL) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Adlai Nortye (ANL) Cayman Islands $0.061B 0.00
Opus Genetics (IRD) United States $0.060B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Immix Biopharma (IMMX) United States $0.059B 0.00
Kalaris Therapeutics (KLRS) United States $0.058B 0.00
Clearside Biomedical (CLSD) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.057B 0.00
Akoya Biosciences (AKYA) United States $0.057B 0.00
Celularity (CELU) United States $0.056B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Adverum Biotechnologies (ADVM) United States $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
Annovis Bio (ANVS) United States $0.051B 0.00
Applied Therapeutics (APLT) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
PepGen (PEPG) United States $0.050B 0.00
Atara Biotherapeutics (ATRA) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Shattuck Labs (STTK) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Quince Therapeutics (QNCX) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
Connect Biopharma Holdings (CNTB) United States $0.045B 0.00
Rein Therapeutics (RNTX) United States $0.045B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.044B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.044B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.043B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Quantum Biopharma (QNTM) Canada $0.042B 0.00
Kronos Bio (KRON) United States $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.039B 0.00
Scilex Holding (SCLX) United States $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Aligos Therapeutics (ALGS) United States $0.036B 0.00
OnKure Therapeutics (OKUR) United States $0.036B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Clene (CLNN) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Medicus Pharma (MDCX) United States $0.034B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.034B 0.00
Imunon (IMNN) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
Passage Bio (PASG) United States $0.031B 0.00
BioAtla (BCAB) United States $0.031B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Estrella Immunopharma (ESLA) United States $0.030B 0.00
FibroBiologics (FBLG) United States $0.030B 0.00
Oncolytics Biotech (ONCY) Canada $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
ALX Oncology Holdings (ALXO) United States $0.030B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.029B 0.00
Grace Therapeutics (GRCE) Canada $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
ABVC BioPharma (ABVC) United States $0.028B 0.00
Vor Biopharma (VOR) $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
Generation Bio (GBIO) United States $0.027B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.026B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Curis (CRIS) United States $0.024B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.024B 0.00
Q32 Bio (QTTB) United States $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
X4 Pharmaceuticals (XFOR) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Femasys (FEMY) United States $0.022B 0.00
Advanced Biomed (ADVB) United States $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
Elevation Oncology (ELEV) United States $0.018B 0.00
Longeveron (LGVN) United States $0.018B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Rallybio (RLYB) United States $0.012B 0.00
Hoth Therapeutics (HOTH) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Dogwood Therapeutics (DWTX) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
HCW Biologics (HCWB) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Intensity Therapeutics (INTS) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Eyenovia (EYEN) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00